OGEN

7:47 am Oragenics advances towards identification of lead antibiotic clinical candidate; lantibiotic pipeline through exclusive channel collaboration with XON generates several new MU1140 analogs with activity against certain drug-resistant

moreView todays social media effects on OGENView the latest stocks trending across Twitter. Click to view dashboardSee who Oragenics is hiring next, click here to view […]

Oragenics Advances Towards Identification of Lead Antibiotic Clinical Candidate

[Business Wire] – Oragenics, Inc. announced today that through its Exclusive Channel Collaboration with Intrexon Corporation , a leader in synthetic biology, it has produced and analyzed a large number of new potential analogs generated from its Mutacin moreView todays social media effects on OGENView the latest stocks trending across Twitter. Click to view dashboardSee who Oragenics is hiring […]

ORAGENICS INC Files SEC form 10-K, Annual Report

moreView todays social media effects on OGENView the latest stocks trending across Twitter. Click to view dashboardSee who Oragenics is hiring next, click here to view […]

April 8, 2013 – Oragenics Announces Approval of Common Stock Listing on NYSE MKT

[at noodls] – Oragenics Announces Approval of Common Stock Listing on NYSE MKT TAMPA, Fla. (April 8, 2013)-Oragenics, Inc. (OTCBB: OGEN) (the Company) announced today that its common stock has been approved … moreView todays social media effects on OGENView the latest stocks trending across Twitter. Click to view dashboardSee who Oragenics is hiring next, click here to view […]

Oragenics Announces Approval of Common Stock Listing on NYSE MKT

[Business Wire] – Oragenics, Inc. announced today that its common stock has been approved for listing on the NYSE Euronext’s NYSE MKT. Trading is expected to commence o moreView todays social media effects on OGENView the latest stocks trending across Twitter. Click to view dashboardSee who Oragenics is hiring next, click here to view […]

ORAGENICS INC Files SEC form 10-K, Annual Report

moreView todays social media effects on OGENView the latest stocks trending across Twitter. Click to view dashboardSee who Oragenics is hiring next, click here to view […]

March 12, 2013 – Oragenics Receives First European Patent for ProBiora3 Probiotic Blend

[at noodls] – Oragenics Receives First European Patent for ProBiora3 Probiotic Blend TAMPA, FL – March 12, 2013 – Oragenics, Inc. (OTCQB and OTCBB: OGEN) today announced it has received its first patent approval in … moreView todays social media effects on OGENView the latest stocks trending across Twitter. Click to view dashboardSee who Oragenics is hiring next, click here […]